An FDA panel voted to allow six peptides for pharmacy compounding despite safety objections and conflicts of interest.

The panel’s recommendations could shape the future of popular peptides, but some doctors say the review process itself ...

An FDA panel voted to recommend six peptides including BPC-157, TB-500, and KPV for compounding by licensed pharmacies ...

Advisers to the Food and Drug Administration voted in favor of easing regulation of popular peptides. The recommendations could pave the way for specialized pharmacies to produce them in the U.S.

Though FDA would normally follow a panel’s advice to move ahead with compounded peptides, it’s unclear how it will act, ...

This week, the FDA's Pharmacy Compounding Advisory Committee largely voted yes to allowing several peptides be produced by compounding pharmacies.

But they might become easier to get. Let us explain.

The group met on July 24 to vote on whether compounding pharmacies could legally dispense certain peptides.

Outside experts—some with a vested interest in peptides—recommended adding a number of the amino acids to the FDA’s bulks list, including the “Wolverine stack” touted by Joe Rogan and other ...

Against a backdrop of public sentiment and statements pushing rapid adoption of peptides, FDA's PCAC recommends allowing use of six peptides ...

An FDA committee just voted to ease regulations on six popular peptides. There are still many unanswered questions about ...

Dr. Pieter Cohen told Newsweek there is "absolutely not" enough evidence these peptides are safe for human use.